Skip to main content
. 2019 Sep 23;57(1):625–631. doi: 10.1080/13880209.2019.1657905

Figure 5.

Figure 5.

SU-induced AMPK/mTOR activation inhibition in H9c2 cardiomyocytes is reversed by TMZ. (A, B) Western blots of AMPK/mTOR pathway in vehicle-, SU- and SU-TMZ-treated H9c2 cardiomyocytes and statistical analysis (n = 5, 6, 4, 4, respectively). (The Student’s two-tailed t-test was used, error bar = SEM, *p < 0.05, ****p < 0.0001).